Emerging therapies bring hope for frail HNSCC patients unfit for standard treatment
The number of diagnosed incident cases of head and neck squamous cell carcinoma (HNSCC) are projected to climb from 229,000…
The number of diagnosed incident cases of head and neck squamous cell carcinoma (HNSCC) are projected to climb from 229,000…
Last year saw the largest fall in US contract manufacturing (CM) deals for FDA-approved drugs in five years. Despite the…
GlobalData anticipates notable growth in the head and neck squamous cell carcinoma (HNSCC) therapeutics market across the eight major markets…
At the American College of Cardiology (ACC) Annual Scientific Session & Expo 2026, a systematic review and meta-analysis of sotatercept in pulmonary…
On 28 March, at the American College of Cardiology (ACC) 75th Annual Scientific Session & Expo in New Orleans, Louisiana,…
Type 2 diabetes (T2D) and heart health have a complex and dependent relationship. New data presented at ACC 2026 suggests…
At the 2026 American College of Cardiology (ACC) Scientific Session in New Orleans, the phase II CADENCE trial reported results…
At the 2026 American College of Cardiology (ACC) Scientific Session in New Orleans, the KARDINAL phase II trial assessed tonlamarsen,…
At the 2026 American College of Cardiology (ACC) Scientific Session in New Orleans, researchers presented a meta-analysis of randomized trials…
At the 2026 American College of Cardiology (ACC) Scientific Session in New Orleans, investigators from Brazil presented a systematic review…